Drug Trial Radar · NCT03674008
A Phase III Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or Anesthesia
Last checked: Nov 19, 2026Latest source record: Jul 5, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
280
Actual
Start
Oct 9, 2018
Primary completion
Jan 9, 2019
Study completion Mar 10, 2019
Sponsor
- Lead sponsor
- Sichuan Haisco Pharmaceutical Group Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Sep 17, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase III, randomized, double-blind, propofol-controlled, parallel-design, multi-center study to evaluate the efficacy and safety of HSK3486 for sedation or anesthesia in patients undergoing colonoscopy and gastroscopy. The study will enroll approximately 280 adults. The maximum study duration is anticipated to be up to nine months.
Conditions
- Sedation or Anesthesia
Interventions
HSK3486Drug
HSK3486 intravenous (iv) 0.4 mg/kg for induction, and 0.2 mg/kg top-ups for maintenance.
PropofolDrug
Propofol iv 1.5 mg/kg for induction, and 0.75 mg/kg top-ups for maintenance.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Success of colonoscopy procedureTime frame: from the first dose of the study drug to removal of colonoscope on day 1
Locations
1 site in 1 country. Site status is shown where the registry gives one.
West China Hospital, Sichuan University
Changde, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.